全球高通量篩選市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測
市場調查報告書
商品編碼
1307013

全球高通量篩選市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023至2030年預測

Global High Throughput Screening Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 255 Pages | 商品交期: 最快1-2個工作天內

價格

高通量篩選市場的全球需求預計將從2022年的202.9億美元成長到2030年的963.8億美元,2023-2030年的複合年成長率為21.5%。

高通量篩選(HTS)是一種用於藥物發現和分子生物學的方法,可快速有效地測試大量化學合成物或生物分子與感興趣的靶點相互作用的能力。 HTS的目標是確定潛在的候選藥物或能夠調節特定靶標(如蛋白質或酶)活性的生物分子。 HTS涉及使用自動化系統、機器人技術和先進的數據分析工具在短時間內篩選數千甚至數百萬個化合物或分子。通常情況下,針對感興趣的靶點篩選大量化合物或分子庫,並在更詳細的研究中進一步評估顯示出良好活性的化合物。

市場動態:

隨著癌症、阿滋海默症和自身免疫性疾病等各種疾病的發病率不斷上升,對新藥研發的需求也日益增加。 HTS使研究人員能夠快速篩選大量化合物,從而幫助確定潛在的候選藥物。先進的自動篩選系統、機器人技術和數據分析工具的發展提高了HTS的效率和準確性。這使得研究人員能夠更快、更有效地篩選出更多化合物,從而減少藥物研發的時間和成本。製藥和生物技術領域的公司以及學術研究機構不斷增加的投資促進了HTS市場的成長。政府對製藥和生物技術行業研發活動的資助進一步促進了HTS市場的成長。隨著個性化醫療的興起,對靶向藥物療法的需求日益成長。通過對大量化合物進行篩選並確定對特定患者最有效的化合物,HTS在個性化醫療的發展中發揮著至關重要的作用。癌症和糖尿病等慢性疾病的增加導致對新藥物療法的需求日益成長。 HTS可以加速發現新的候選藥物,使其成為開發慢性病新療法的重要工具。

研究報告包括波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於在全球範圍內清晰地了解行業結構並評估競爭吸引力。此外,這些工具還對全球高通量篩選市場的各個細分市場進行了全面評估。高通量篩選行業的成長和趨勢為本研究提供了整體方法。

市場細分:

高通量篩選市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品和服務分類

  • 耗材(試劑和檢測試劑盒、實驗室設備)
  • 儀器(液體處理系統、檢測系統、其他儀器)
  • 服務
  • 軟體

按技術分類

  • 細胞檢測(二維細胞培養、3D細胞培養、報告基因檢測、灌注細胞培養)
  • 晶片實驗室技術(LOC)
  • 無標記技術

按應用

  • 藥物發現
  • 生化篩選
  • 生命科學研究
  • 其他應用

按最終用戶

  • 製藥公司% 生物技術公司
  • 學術研究機構
  • 契約研究組織

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太、拉丁美洲、中東和非洲地區高通量篩選市場的當前和未來需求。此外,報告還重點介紹了所有主要地區各個應用領域的需求、估計和預測。

  • 全球高通量篩選市場的地區佔有率(代表圖)
  • 全球高通量篩選市場佔有率

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。高通量篩選市場的主要參與者包括賽默飛世爾科技公司、安捷倫科技公司、丹納赫公司、珀金埃爾默公司、泰康Group Limited、AXXAM SpA、默克公司、Bio-Ras實驗室公司、普羅米加公司、康寧公司和歐陸科學公司。本部分包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

目 錄

第一章:前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張(USP)和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章:執行摘要

  • 市場亮點
  • 全球市場概況

第三章:高通量篩選-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按產品和服務分類的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 市場吸引力分析:按應用
    • 市場吸引力分析:按最終用戶
    • 市場吸引力分析:按地區

第四章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章:全球高通量篩選市場分析:按產品和服務分類

  • 產品和服務概述
  • 歷史和預測數據
  • 按產品和服務分析
  • 耗材(試劑和檢測試劑盒、實驗室設備)
  • 儀器(液體處理系統、檢測系統、其他儀器)
  • 服務
  • 軟體

第六章:全球高通量篩選市場分析:按技術分類

  • 技術概述
  • 歷史和預測數據
  • 按技術分析
  • 細胞檢測(二維細胞培養、3D細胞培養、報告基因檢測、灌注細胞培養)
  • 晶片實驗室技術(LOC)
  • 無標記技術

第七章:全球高通量篩選市場分析:按應用分類

  • 概述:按應用分類
  • 歷史和預測數據
  • 分析:按應用
  • 藥物發現
  • 生化篩選
  • 生命科學研究
  • 其他應用

第八章:全球高通量篩選市場分析:按終端用戶分類

  • 終端用戶概述
  • 歷史和預測數據
  • 按最終用戶分析
  • 製藥公司
  • 學術研究機構
  • 契約研究組織

第九章:全球高通量篩選市場分析:按地域分類

  • 地區展望
  • 地區介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東及非洲地區銷售分析
    • 中東及非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第10章: 高通量篩選企業競爭格局

  • 高通量篩選市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品上市
  • 其他發展

第十一章:公司概況

  • 公司佔有率分析
  • 市場集中率
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Danaher Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • PerkinElmer Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Tecan Group Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • AXXAM SpA
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Merck KGaA
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Bio-Ras Laboratories Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Promega Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Corning Incorporated
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Eurofins Scientific.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中,財務細節和近期發展視情況而定,如果是私營公司則可能不包括在內。

Product Code: VMR112110818

The global demand for High-Throughput Screening Market is presumed to reach the market size of nearly USD 96.38 BN by 2030 from USD 20.29 BN in 2022 with a CAGR of 21.5% under the study period 2023 - 2030.

High-throughput screening (HTS) is a method used in drug discovery and molecular biology to quickly and efficiently test a large number of chemical compounds or biological molecules for their ability to interact with a target of interest. The goal of HTS is to identify potential drug candidates or biological molecules that can modulate the activity of a specific target, such as a protein or enzyme. HTS involves the use of automated systems, robotics, and advanced data analysis tools to screen thousands or even millions of compounds or molecules in a short period of time. Typically, a large library of compounds or molecules is screened against a target of interest, and the compounds that show promising activity are further evaluated in more detailed studies.

Market Dynamics:

With the growing prevalence of various diseases such as cancer, Alzheimer's disease, and autoimmune disorders, there is an increasing demand for novel drug discovery. HTS enables researchers to screen a large number of compounds rapidly, which helps in identifying potential candidates for drug development. The development of advanced automated screening systems, robotics, and data analysis tools has led to improvements in the efficiency and accuracy of HTS. This has enabled researchers to screen a larger number of compounds more quickly and efficiently, reducing the time and cost of drug discovery. The increasing investments by companies operational in the pharmaceutical and biotechnology field, as well as academic research institutions, have contributed to the growth of the HTS market. The government initiatives for funding research and development activities in the pharmaceutical and biotechnology industries have further contributed to the growth of the HTS market. With the rise of personalized medicine, there is a growing need for targeted drug therapies. HTS plays a crucial role in the development of personalized medicine by enabling the screening of a large number of compounds and identifying the ones that are most effective for a specific patient. The growth in chronic diseases, such as cancer and diabetes, has led to a growing need for new drug therapies. HTS can accelerate the discovery of new drug candidates, making it an important tool in the development of new treatments for chronic diseases.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of high-throughput screening. The growth and trends of high-throughput screening industry provide a holistic approach to this study.

Market Segmentation:

This section of the high-throughput screening market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Consumables (Reagents & Assay Kits, Laboratory Equipment)
  • Instruments (Liquid Handling Systems, Detection Systems, Other Instruments)
  • Services
  • Software

By Technology

  • Cell-Based Assays (2D Cell Culture, 3D Cell Culture, Reporter-Based Assays, Perfusion Cell Culture)
  • Lab-On-A-Chip Technology (LOC)
  • Label-Free Technology

By Application

  • Drug Discovery
  • Biochemical Screening
  • Life Sciences Research
  • Other Applications

By End User

  • Pharmaceutical % Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the High-Throughput Screening market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • Global High-Throughput Screening Market Share by Region (Representative Graph)
  • Global High-Throughput Screening Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the high-throughput screening market include Thermo Fisher Scientific Inc., Agilent Technologies Inc., Danaher Corporation, PerkinElmer Inc., Tecan Group Ltd., AXXAM S.p.A., Merck KGaA, Bio-Ras Laboratories Inc., Promega Corporation, Corning Incorporated and Eurofins Scientific. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . HIGH-THROUGHPUT SCREENING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY PRODUCT & SERVICE

  • 5.1 Overview by Product & Service
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Product & Service
  • 5.4 Consumables (Reagents & Assay Kits, Laboratory Equipment) Historic and Forecast Sales by Regions
  • 5.5 Instruments (Liquid Handling Systems, Detection Systems, Other Instruments) Historic and Forecast Sales by Regions
  • 5.6 Services Historic and Forecast Sales by Regions
  • 5.7 Software Historic and Forecast Sales by Regions

6 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Cell-based Assays (2D Cell Culture, 3D Cell Culture, Reporter-based Assays, Perfusion Cell Culture) Historic and Forecast Sales by Regions
  • 6.5 Lab-on-a-Chip Technology (LOC) Historic and Forecast Sales by Regions
  • 6.6 Label-free Technology Historic and Forecast Sales by Regions

7 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Drug Discovery Historic and Forecast Sales by Regions
  • 7.5 Biochemical Screening Historic and Forecast Sales by Regions
  • 7.6 Life Sciences Research Historic and Forecast Sales by Regions
  • 7.7 Other Applications Historic and Forecast Sales by Regions

8 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Pharmaceutical % Biotechnology Companies Historic and Forecast Sales by Regions
  • 8.5 Academic & Research Institutes Historic and Forecast Sales by Regions
  • 8.6 Contract Research Organizations Historic and Forecast Sales by Regions

9 . GLOBAL HIGH-THROUGHPUT SCREENING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE HIGH-THROUGHPUT SCREENING COMPANIES

  • 10.1. High-Throughput Screening Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF HIGH-THROUGHPUT SCREENING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Agilent Technologies Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Danaher Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. PerkinElmer Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Tecan Group Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. AXXAM S.p.A.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Merck KGaA
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Bio-Ras Laboratories Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Promega Corporation
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Corning Incorporated
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Eurofins Scientific.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Consumables (Reagents & Assay Kits, Laboratory Equipment) Market Sales by Geography (USD MN)
  • Instruments (Liquid Handling Systems, Detection Systems, Other Instruments) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Cell-based Assays (2D Cell Culture, 3D Cell Culture, Reporter-based Assays, Perfusion Cell Culture) Market Sales by Geography (USD MN)
  • Lab-on-a-Chip Technology (LOC) Market Sales by Geography (USD MN)
  • Label-free Technology Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Biochemical Screening Market Sales by Geography (USD MN)
  • Life Sciences Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical % Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Global High-Throughput Screening Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of High-Throughput Screening Report
  • Market Research Process
  • Market Research Methodology
  • Global High-Throughput Screening Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Consumables (Reagents & Assay Kits, Laboratory Equipment) Market Sales by Geography (USD MN)
  • Instruments (Liquid Handling Systems, Detection Systems, Other Instruments) Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Software Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Cell-based Assays (2D Cell Culture, 3D Cell Culture, Reporter-based Assays, Perfusion Cell Culture) Market Sales by Geography (USD MN)
  • Lab-on-a-Chip Technology (LOC) Market Sales by Geography (USD MN)
  • Label-free Technology Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Drug Discovery Market Sales by Geography (USD MN)
  • Biochemical Screening Market Sales by Geography (USD MN)
  • Life Sciences Research Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical % Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Contract Research Organizations Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.